Literature DB >> 15236455

Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity.

Anand Balakrishnan1, Bhagwant D Rege, Gordon L Amidon, James E Polli.   

Abstract

The objective of this study was to assess the contributions of surfactant-mediated solubility and micellar diffusivity on the ability of surfactant to enhance drug dissolution. The following model was derived to predict the degree to which surfactants enhance griseofulvin dissolution: phi = 1 + (fm/ff).((D(D-M)2/3)/(DD2/3)) where phi is the degree of surfactant-mediated dissolution enhancement, fm is the fraction of the drug in micelle, and ff is the fraction of free drug, and DD and D(D-M) are the diffusivities of free drug and drug-loaded micelles, respectively. The Wood apparatus was used to measure the dissolution of griseofluvin in the presence of the anionic surfactant sodium dodecyl sulfate (SDS), the cationic surfactant cetyl trimethyl ammonium bromide (CTAB), and the neutral surfactants Tween 80 and Cremophor EL. DD was estimated using the Levich equation. D(D-M) was measured using dynamic light scattering. Griseofulvin solubility was evaluated in SDS, CTAB, Tween 80, and Cremophor EL at the surfactant concentrations used in the dissolution studies. DD was 11.0 x 10(-6) cm2/s. D(D-M) was 1.29 x 10(-6) cm2/s, 0.956 x 10(-6) cm2/s, 0.569 x 10(-6) cm2/s, and 0.404 x 10(-6) cm2/s for griseofulvin-loaded micelles of SDS, CTAB, Tween 80, and Cremophor EL, respectively. At the highest surfactant concentrations studied, griseofulvin solubility increased 107-fold, 31-fold, fourfold, and threefold for SDS, CTAB, Tween 80, and Cremophor EL. Dissolution into SDS and CTAB were markedly enhanced, but only about one-third as much as solubility enhancement. Dissolution enhancement in the presence of SDS and CTAB were in excellent agreement with model predicted values, with prediction error less than 12%. The model predicted dissolution into Tween 80 and Cremophor EL to be minimally enhanced, as was observed, although the model underpredicted dissolution into these two neutral surfactants. The derived model predicted surfactant-mediated dissolution and reflects dissolution enhancement to be promoted by surfactant-enhanced solubility, but limited by the relatively slow diffusion of drug-loaded surfactant micelles. Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:2064-2075, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236455     DOI: 10.1002/jps.20118

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Fabrication of cyclodextrin-templated mesoporous silica for improved dissolution of carbamazepine.

Authors:  Meer Tarique Ali; Ritesh Fule; Ajay Sav; Purnima Amin
Journal:  Drug Deliv Transl Res       Date:  2013-06       Impact factor: 4.617

2.  Intragastric floating drug delivery system of cefuroxime axetil: in vitro evaluation.

Authors:  Viral F Patel; Natavarlal M Patel
Journal:  AAPS PharmSciTech       Date:  2006-02-24       Impact factor: 3.246

3.  Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers.

Authors:  Jennifer J Sheng; Daniel P McNamara; Gordon L Amidon
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

4.  Pluronic and tetronic copolymers with polyglycolyzed oils as self-emulsifying drug delivery systems.

Authors:  Marta Fernandez-Tarrio; Fernando Yañez; Kristof Immesoete; Carmen Alvarez-Lorenzo; Angel Concheiro
Journal:  AAPS PharmSciTech       Date:  2008-03-14       Impact factor: 3.246

5.  Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs.

Authors:  Shasha Rao; Yunmei Song; Frank Peddie; Allan M Evans
Journal:  Int J Nanomedicine       Date:  2011-06-20

6.  Surfactants modify the release from tablets made of hydrophobically modified poly (acrylic acid).

Authors:  Patrik Knöös; Sebla Onder; Lina Pedersen; Lennart Piculell; Stefan Ulvenlund; Marie Wahlgren
Journal:  Results Pharma Sci       Date:  2013-09-13

7.  Formulation of the microbicide INP0341 for in vivo protection against a vaginal challenge by Chlamydia trachomatis.

Authors:  Christian Pedersen; Anatoly Slepenkin; Sara B E Andersson; Jonas H Fagerberg; Christel A S Bergström; Ellena M Peterson
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

8.  Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties.

Authors:  Deanna M Mudie; Nasim Samiei; Derrick J Marshall; Gregory E Amidon; Christel A S Bergström
Journal:  AAPS J       Date:  2020-01-27       Impact factor: 4.009

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.